On the other hand, some complement proteins, such as C1q and C3, are pathologically increased in the CSF of patients with MS, where elevated C3 levels correlate significantly with disease progression (97), and in cerebral ischemia (98). This evidence concerns the gene C3 and myeloid sarcoma.